[go: up one dir, main page]

NO941108L - Fremgangsmåte ved fremstilling av antimikrobielle kinolonyllaktamer - Google Patents

Fremgangsmåte ved fremstilling av antimikrobielle kinolonyllaktamer

Info

Publication number
NO941108L
NO941108L NO941108A NO941108A NO941108L NO 941108 L NO941108 L NO 941108L NO 941108 A NO941108 A NO 941108A NO 941108 A NO941108 A NO 941108A NO 941108 L NO941108 L NO 941108L
Authority
NO
Norway
Prior art keywords
quinolone
compound
lactam
moiety
steps
Prior art date
Application number
NO941108A
Other languages
English (en)
Other versions
NO304599B1 (no
NO941108D0 (no
Inventor
Ronald Eugene White
Jr Thomas Prosser Demuth
Original Assignee
Procter & Gamble Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble Pharma filed Critical Procter & Gamble Pharma
Publication of NO941108D0 publication Critical patent/NO941108D0/no
Publication of NO941108L publication Critical patent/NO941108L/no
Publication of NO304599B1 publication Critical patent/NO304599B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D505/00Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02Preparation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO941108A 1991-10-01 1994-03-25 FremgangsmÕte ved fremstilling av antimikrobielle kinolonyllaktamer NO304599B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76961591A 1991-10-01 1991-10-01
PCT/US1992/008246 WO1993007154A1 (en) 1991-10-01 1992-09-28 Process for making antimicrobial quinolonyl lactams

Publications (3)

Publication Number Publication Date
NO941108D0 NO941108D0 (no) 1994-03-25
NO941108L true NO941108L (no) 1994-05-31
NO304599B1 NO304599B1 (no) 1999-01-18

Family

ID=25085987

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941108A NO304599B1 (no) 1991-10-01 1994-03-25 FremgangsmÕte ved fremstilling av antimikrobielle kinolonyllaktamer

Country Status (22)

Country Link
US (1) US5281703A (no)
EP (1) EP0606336B1 (no)
KR (1) KR100253825B1 (no)
CN (1) CN1046523C (no)
AT (1) ATE150463T1 (no)
AU (1) AU667837B2 (no)
BR (1) BR9206590A (no)
CA (1) CA2120493A1 (no)
CZ (1) CZ73194A3 (no)
DE (1) DE69218445T2 (no)
DK (1) DK0606336T3 (no)
ES (1) ES2101119T3 (no)
FI (1) FI941490L (no)
GR (1) GR3023227T3 (no)
HU (1) HUT67423A (no)
MX (1) MX9205620A (no)
NO (1) NO304599B1 (no)
NZ (1) NZ244557A (no)
PT (1) PT100920B (no)
RU (1) RU2130938C1 (no)
SK (1) SK37594A3 (no)
WO (1) WO1993007154A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646163A (en) * 1992-10-30 1997-07-08 The Procter & Gamble Company Quinolone 5-(N-heterosubstituted amino) antimicrobials
DE69431684T2 (de) * 1993-12-28 2003-03-20 Kao Corp., Tokio/Tokyo Vernetzte Zellulosefasern, absorbierende Papiere und absorbierende Elemente, Deckschicht und absorbierende Gegenstände, wobei diese Fasern Verwendung finden
EP0775114B1 (en) * 1994-08-02 2000-03-22 The Procter & Gamble Company Process for making antimicrobial compounds
JPH10503521A (ja) * 1994-08-02 1998-03-31 ザ、プロクター、エンド、ギャンブル、カンパニー キノロニルラクタム抗微生物剤の製造方法及び新規中間化合物
EP0695753A1 (en) * 1994-08-05 1996-02-07 Zeneca Limited Carbapenem derivatives containing a bicyclic substituent, process for their preparation, and their use
US5607928A (en) * 1994-08-05 1997-03-04 Zeneca Limited Carbapenem derivatives containing a bicyclic ketone substituent and their use as anti-infectives
US5693791A (en) * 1995-04-11 1997-12-02 Truett; William L. Antibiotics and process for preparation
EP0970065A4 (en) * 1997-11-29 2001-03-07 William L Truett ANTIBIOTICS AND THEIR PREPARATION PROCESS
US6437119B1 (en) 1998-05-07 2002-08-20 William Lawrence Truett Compounds formed from two or three antibiotics and their processes of preparation
US6638908B1 (en) * 2000-08-09 2003-10-28 Yale University Crystals of the large ribosomal subunit
US6947844B2 (en) * 2000-08-09 2005-09-20 Yale University Modulators of ribosomal function and identification thereof
IN191798B (no) 2000-11-03 2004-01-03 Ranbaxy Lab Ltd
DE60101724T2 (de) 2001-03-30 2004-12-02 Dar Al Dawa Development, And Investment Co. Chinolin-4-on Derivate und deren Verwendung als Antibiotika
IL151012A0 (en) * 2001-08-03 2003-02-12 Ribosomes Structure And Protei Ribosomes structure and protein synthesis inhibitors
US6952650B2 (en) 2001-08-03 2005-10-04 Yale University Modulators of ribosomal function and identification thereof
US7091196B2 (en) 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
AU2004217919A1 (en) * 2003-03-05 2004-09-16 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using the same
WO2005042554A1 (en) * 2003-10-30 2005-05-12 Rib-X Pharmaceuticals, Inc. Bifunctional macrolide heterocyclic compounds and methods of making and using the same
US20070270357A1 (en) * 2003-11-18 2007-11-22 Farmer Jay J Bifunctional Macrolide Heterocyclic Compounds and Methods of Making and Using the Same
EP1723159B1 (en) 2004-02-27 2019-06-12 Melinta Therapeutics, Inc. Macrocyclic compounds and methods of making and using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT49889A (en) * 1988-03-31 1989-11-28 Hoffmann La Roche Process for producing acyl derivatives
EP0366641B1 (en) * 1988-10-24 2000-07-05 Norwich Eaton Pharmaceuticals, Inc. Novel antimicrobial quinolonyl lactam esters
EP0366193A3 (en) * 1988-10-24 1992-01-08 Norwich Eaton Pharmaceuticals, Inc. Novel antimicrobial quinolonyl lactams
EP0997466A1 (en) * 1988-10-24 2000-05-03 PROCTER & GAMBLE PHARMACEUTICALS, INC. Novel antimicrobial lactam-quinolones
SG54293A1 (en) * 1988-10-24 1998-11-16 Procter & Gamble Pharma Novel antimicrobial fluoroquinolonyl cephems
ZA912279B (en) * 1990-04-09 1992-02-26 Hoffmann La Roche Carbapenem compounds
DE69132256T2 (de) * 1990-04-18 2001-01-25 Procter & Gamble Pharmaceuticals, Inc. Antimikrobielle chinolonyl-lactame

Also Published As

Publication number Publication date
DE69218445D1 (de) 1997-04-24
BR9206590A (pt) 1995-04-25
DK0606336T3 (da) 1997-04-14
AU667837B2 (en) 1996-04-18
EP0606336B1 (en) 1997-03-19
WO1993007154A1 (en) 1993-04-15
FI941490A7 (fi) 1994-05-02
CN1046523C (zh) 1999-11-17
MX9205620A (es) 1993-12-01
AU2693892A (en) 1993-05-03
ES2101119T3 (es) 1997-07-01
NZ244557A (en) 1996-02-27
CZ73194A3 (en) 1994-11-16
HUT67423A (en) 1995-04-28
DE69218445T2 (de) 1997-08-07
ATE150463T1 (de) 1997-04-15
FI941490A0 (fi) 1994-03-30
SK37594A3 (en) 1995-02-08
CA2120493A1 (en) 1993-04-15
KR100253825B1 (ko) 2000-05-01
US5281703A (en) 1994-01-25
RU2130938C1 (ru) 1999-05-27
PT100920A (pt) 1993-10-29
NO304599B1 (no) 1999-01-18
FI941490L (fi) 1994-05-02
PT100920B (pt) 1999-07-30
NO941108D0 (no) 1994-03-25
GR3023227T3 (en) 1997-07-30
HU9400940D0 (en) 1994-06-28
CN1075146A (zh) 1993-08-11
EP0606336A1 (en) 1994-07-20

Similar Documents

Publication Publication Date Title
NO941108L (no) Fremgangsmåte ved fremstilling av antimikrobielle kinolonyllaktamer
RU94018240A (ru) Способ получения антимикробных хинолониллактамов
CA2238864A1 (en) Method for the synthesis of a benzimidazole compound
EP0573667A4 (no)
GR3026737T3 (en) Tri-higher alkyl tin azide and its use.
NO834331L (no) Fremgangsmaate ved fremstilling av penemforbindelser
IE57609B1 (en) Process for the production of penems
IN167606B (no)
DE69322673D1 (de) Imidazopyridazine als Antiasthmatika
CA2196539A1 (en) Process for making quinolonyl lactam antimicrobials and novel intermediate compounds
CA1248520A (en) Penem compounds, pharmaceutical compositions containing them, processes for their preparation
CA2263268A1 (en) Process for the preparation of 3-amino-2-hydroxy-1-propyl ethers
NO931105L (no) Fremgangsmaate for fremstilling av et 4-substituert azetidinonderivat
IE801598L (en) Azetidinones.
EP0165272A1 (en) Heterocyclic substituted penems
DE3864163D1 (de) Beta-lactam-verbindungen und verfahren zu deren herstellung.
FI872135A0 (fi) Foerfarande foer framstaellning av kefalosporinderivat.
KR930017901A (ko) 카바세펨의 제조를 위한 신규한 방법 및 화합물
MY105332A (en) Process for preparing penem esters
EP0844247A4 (en) METHOD FOR PRODUCING 3-NORCEPHEMIC COMPOUNDS
ATE210115T1 (de) Verfahren zur herstellung von (1'r,3s,4r)4- acylthioazetidinonen
MX9706606A (es) Procedimiento para la preparacion del monohidrato de loracarbef.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN MARCH 2002